{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T03:50:56Z","timestamp":1794282656586,"version":"4.9.0"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T00:00:00Z","timestamp":1729296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T00:00:00Z","timestamp":1729296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["2142917"],"award-info":[{"award-number":["2142917"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DMR1905559"],"award-info":[{"award-number":["DMR1905559"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["RSG-19-009-01-CDD"],"award-info":[{"award-number":["RSG-19-009-01-CDD"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["T32GM139789"],"award-info":[{"award-number":["T32GM139789"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-53396-x","type":"journal-article","created":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T06:02:27Z","timestamp":1729317747000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Sprayable inflammasome-inhibiting lipid nanorods in a polymeric scaffold for psoriasis therapy"],"prefix":"10.1038","volume":"15","author":[{"given":"Dhanashree","family":"Surve","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8238-0240","authenticated-orcid":false,"given":"Adam","family":"Fish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maharshi","family":"Debnath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniruddha","family":"Pinjari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6517-6897","authenticated-orcid":false,"given":"Adrian","family":"Lorenzana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumi","family":"Piya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7364-8727","authenticated-orcid":false,"given":"Shelly","family":"Peyton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5713-2202","authenticated-orcid":false,"given":"Ashish","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,19]]},"reference":[{"key":"53396_CR1","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong, A. W. & Read, C. Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review. JAMA - J. Am. Med. Assoc. 323, 1945\u20131960 (2020).","journal-title":"JAMA - J. Am. Med. Assoc."},{"key":"53396_CR2","unstructured":"Global Report on Psoriasis; 2016."},{"key":"53396_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms20061475","volume":"20","author":"A Rendon","year":"2019","unstructured":"Rendon, A. & Sch\u00e4kel, K. Psoriasis Pathogenesis and Treatment. Int. J. Mol. Sci. 20, 1\u201328 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"53396_CR4","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/1346-8138.15913","volume":"48","author":"K Yamanaka","year":"2021","unstructured":"Yamanaka, K., Yamamoto, O. & Honda, T. Pathophysiology of Psoriasis: A Review. J. Dermatol. 48, 722\u2013731 (2021).","journal-title":"J. Dermatol."},{"key":"53396_CR5","doi-asserted-by":"publisher","unstructured":"Zhou, X., Chen, Y., Cui, L., Shi, Y., Guo, C. Advances in the Pathogenesis of Psoriasis: From Keratinocyte Perspective. Cell Death Dis. 13 https:\/\/doi.org\/10.1038\/s41419-022-04523-3 (2022).","DOI":"10.1038\/s41419-022-04523-3"},{"key":"53396_CR6","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.jid.2020.07.012","volume":"141","author":"D Verma","year":"2021","unstructured":"Verma, D. et al. Enhanced Inflammasome Activity in Patients with Psoriasis Promotes Systemic Inflammation. J. Invest. Dermatol. 141, 586\u2013595.e5 (2021).","journal-title":"J. Invest. Dermatol."},{"key":"53396_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22115898","volume":"22","author":"M Ci\u0105\u017cy\u0144ska","year":"2021","unstructured":"Ci\u0105\u017cy\u0144ska, M. et al. The Role of NLRP1, NLRP3, and AIM2 Inflammasomes in Psoriasis: Review. Int. J. Mol. Sci. 22, 1\u201311 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"53396_CR8","doi-asserted-by":"publisher","first-page":"4755","DOI":"10.4049\/jimmunol.0900521","volume":"183","author":"H Wang","year":"2009","unstructured":"Wang, H. et al. Targeting NF-\u039aB with a Natural Triterpenoid Alleviates Skin Inflammation in a Mouse Model of Psoriasis. J. Immunol. 183, 4755\u20134763 (2009).","journal-title":"J. Immunol."},{"key":"53396_CR9","doi-asserted-by":"publisher","unstructured":"Nowowiejska, J. et al. Gasdermin D (GSDMD) Is Upregulated in Psoriatic Skin\u2014A New Potential Link in the Pathogenesis of Psoriasis. Int. J. Mol. Sci. 24 https:\/\/doi.org\/10.3390\/ijms241713047 (2023).","DOI":"10.3390\/ijms241713047"},{"key":"53396_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu13010163","volume":"13","author":"AMA Stanescu","year":"2021","unstructured":"Stanescu, A. M. A., Simionescu, A. A. & Diaconu, C. C. Oral Vitamin D Therapy in Patients with Psoriasis. Nutrients 13, 1\u201312 (2021).","journal-title":"Nutrients"},{"key":"53396_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/dth.14498","volume":"34","author":"A Sadeghinia","year":"2021","unstructured":"Sadeghinia, A. & Daneshpazhooh, M. Immunosuppressive Drugs for Patients with Psoriasis during the COVID-19 Pandemic Era. A Review. Dermatol. Ther. 34, 1\u20139 (2021).","journal-title":"Dermatol. Ther."},{"key":"53396_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s40259-022-00569-z","volume":"37","author":"Y Jiang","year":"2023","unstructured":"Jiang, Y., Chen, Y., Yu, Q. & Shi, Y. Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities. BioDrugs 37, 35\u201355 (2023).","journal-title":"BioDrugs"},{"key":"53396_CR13","doi-asserted-by":"publisher","unstructured":"Timis, T. L., Florian, I. A., Vesa, S. C., Mitrea, D. R., Orasan, R. I. An Updated Guide in the Management of Psoriasis for Every Practitioner; Vol. 75. https:\/\/doi.org\/10.1111\/ijcp.14290 (2021).","DOI":"10.1111\/ijcp.14290"},{"key":"53396_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells9122660","volume":"9","author":"\u0141 Szyma\u0144ski","year":"2020","unstructured":"Szyma\u0144ski, \u0141. et al. Retinoic Acid and Its Derivatives in Skin. Cells 9, 1\u201314 (2020).","journal-title":"Cells"},{"key":"53396_CR15","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/jdv.16245","volume":"34","author":"PCM van de Kerkhof","year":"2020","unstructured":"van de Kerkhof, P. C. M. & de Gruijl, F. R. Phototherapy in the Perspective of the Chronicity of Psoriasis. J. Eur. Acad. Dermatol. Venereol. 34, 926\u2013931 (2020).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"53396_CR16","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.clindermatol.2007.10.025","volume":"26","author":"JD Bos","year":"2008","unstructured":"Bos, J. D. & Spuls, P. I. Topical Treatments in Psoriasis: Today and Tomorrow. Clin. Dermatol. 26, 432\u2013437 (2008).","journal-title":"Clin. Dermatol."},{"key":"53396_CR17","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.tcb.2014.12.009","volume":"25","author":"SK Vanaja","year":"2015","unstructured":"Vanaja, S. K., Rathinam, V. A. K. & Fitzgerald, K. A. Mechanisms of Inflammasome Activation: Recent Advances and Novel Insights. Trends Cell Biol. 25, 308\u2013315 (2015).","journal-title":"Trends Cell Biol."},{"key":"53396_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2021.167251","volume":"434","author":"D Nandi","year":"2022","unstructured":"Nandi, D., Farid, N. S. S., Karuppiah, H. A. R. & Kulkarni, A. Imaging Approaches to Monitor Inflammasome Activation. J. Mol. Biol. 434, 167251 (2022).","journal-title":"J. Mol. Biol."},{"key":"53396_CR19","doi-asserted-by":"publisher","unstructured":"Tan, R. Zhi. et al. Macrophages Mediate Psoriasis via Mincle-Dependent Mechanism in Mice. Cell Death Discov. 9 https:\/\/doi.org\/10.1038\/s41420-023-01444-8 (2023).","DOI":"10.1038\/s41420-023-01444-8"},{"key":"53396_CR20","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ebiom.2016.10.022","volume":"13","author":"X He","year":"2016","unstructured":"He, X. et al. Prokineticin 2 Plays a Pivotal Role in Psoriasis. EBioMedicine 13, 248\u2013261 (2016).","journal-title":"EBioMedicine"},{"key":"53396_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ijid.2022.10.003","volume":"125","author":"Q Tu","year":"2022","unstructured":"Tu, Q. et al. Prokineticin 2 Promotes Macrophages-Mediated Antibacterial Host Defense against Bacterial Pneumonia. Int. J. Infect. Dis. 125, 103\u2013113 (2022).","journal-title":"Int. J. Infect. Dis."},{"key":"53396_CR22","doi-asserted-by":"publisher","unstructured":"Davies, L. C. et al. Distinct Bone Marrow-Derived and Tissue-Resident Macrophage Lineages Proliferate at Key Stages during Inflammation. Nat. Commun. 4 https:\/\/doi.org\/10.1038\/ncomms2877 (2013).","DOI":"10.1038\/ncomms2877"},{"key":"53396_CR23","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1016\/j.jaci.2021.11.024","volume":"149","author":"L Yang","year":"2022","unstructured":"Yang, L. et al. Hsa_circ_0004287 Inhibits Macrophage-Mediated Inflammation in an N6-Methyladenosine\u2013Dependent Manner in Atopic Dermatitis and Psoriasis. J. Allergy Clin. Immunol. 149, 2021\u20132033 (2022).","journal-title":"J. Allergy Clin. Immunol."},{"key":"53396_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.02538","volume":"10","author":"A Zahid","year":"2019","unstructured":"Zahid, A., Li, B., Kombe, A. J. K., Jin, T. & Tao, J. Pharmacological Inhibitors of the Nlrp3 Inflammasome. Front. Immunol. 10, 1\u201310 (2019).","journal-title":"Front. Immunol."},{"key":"53396_CR25","unstructured":"Tuoda, M. A. T., Tu, M., Ana, A. T. A., Att, T., Hati, H. A. N. Lipid Nanoparticles Comprising Lipophilic Anti - Inflammatory Agents and Methods of Use Thereof. 1 (2017)."},{"key":"53396_CR26","doi-asserted-by":"publisher","unstructured":"Dipika, N., Maharshi, D., James, F. I., Ankit, P., Ashish, K. Nanoparticle-Mediated Co-Delivery of Inflammasome Inhibitors Provide Protection against Sepsis. Nanoscale. https:\/\/doi.org\/10.1039\/D3NR05570A (2024).","DOI":"10.1039\/D3NR05570A"},{"key":"53396_CR27","doi-asserted-by":"publisher","first-page":"20057","DOI":"10.1021\/acsnano.2c07843","volume":"16","author":"L Wang","year":"2022","unstructured":"Wang, L. et al. Hyaluronic Acid Nanoparticles as a Topical Agent for Treating Psoriasis. ACS Nano 16, 20057\u201320074 (2022).","journal-title":"ACS Nano"},{"key":"53396_CR28","doi-asserted-by":"publisher","unstructured":"Tsuji, G. et al. Metformin Inhibits IL-1\u03b2 Secretion via Impairment of NLRP3 Inflammasome in Keratinocytes: Implications for Preventing the Development of Psoriasis. Cell Death Discov. 6 https:\/\/doi.org\/10.1038\/s41420-020-0245-8 (2020).","DOI":"10.1038\/s41420-020-0245-8"},{"key":"53396_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.105682","volume":"74","author":"G Deng","year":"2019","unstructured":"Deng, G. et al. Inhibition of NLRP3 Inflammasome-Mediated Pyroptosis in Macrophage by Cycloastragenol Contributes to Amelioration of Imiquimod-Induced Psoriasis-like Skin Inflammation in Mice. Int. Immunopharmacol. 74, 105682 (2019).","journal-title":"Int. Immunopharmacol."},{"key":"53396_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2019.154951","volume":"127","author":"IC Chung","year":"2020","unstructured":"Chung, I. C. et al. EFLA 945 Restricts AIM2 Inflammasome Activation by Preventing DNA Entry for Psoriasis Treatment. Cytokine 127, 154951 (2020).","journal-title":"Cytokine"},{"key":"53396_CR31","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1016\/j.jid.2022.01.010","volume":"142","author":"P Qiao","year":"2022","unstructured":"Qiao, P. et al. Quinolinic Acid, a Tryptophan Metabolite of the Skin Microbiota, Negatively Regulates NLRP3 Inflammasome through AhR in Psoriasis. J. Invest. Dermatol. 142, 2184\u20132193.e6 (2022).","journal-title":"J. Invest. Dermatol."},{"key":"53396_CR32","doi-asserted-by":"publisher","unstructured":"Gaire, B. P. et al. Lysophosphatidic Acid Receptor 5 Contributes to Imiquimod-Induced Psoriasis-Like Lesions through NLRP3 Inflammasome Activation in Macrophages. Cells 9 https:\/\/doi.org\/10.3390\/cells9081753 (2020).","DOI":"10.3390\/cells9081753"},{"key":"53396_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules28196907","volume":"28","author":"M Zamansky","year":"2023","unstructured":"Zamansky, M., Yariv, D., Feinshtein, V., Ben-Shabat, S. & Sintov, A. C. Cannabidiol-Loaded Lipid-Stabilized Nanoparticles Alleviate Psoriasis Severity in Mice: A New Approach for Improved Topical Drug Delivery. Molecules 28, 1\u201316 (2023).","journal-title":"Molecules"},{"key":"53396_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115823","volume":"168","author":"P Rahmanian-Devin","year":"2023","unstructured":"Rahmanian-Devin, P. et al. Preparation and Characterization of Solid Lipid Nanoparticles Encapsulated Noscapine and Evaluation of Its Protective Effects against Imiquimod-Induced Psoriasis-like Skin Lesions. Biomed. Pharmacother. 168, 115823 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"53396_CR35","doi-asserted-by":"publisher","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","volume":"15","author":"R Tenchov","year":"2021","unstructured":"Tenchov, R., Bird, R., Curtze, A. E. & Zhou, Q. Lipid Nanoparticles from Liposomes to MRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement. ACS Nano 15, 16982\u201317015 (2021).","journal-title":"ACS Nano"},{"key":"53396_CR36","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou, X., Zaks, T., Langer, R. & Dong, Y. Lipid Nanoparticles for MRNA Delivery. Nat. Rev. Mater. 6, 1078\u20131094 (2021).","journal-title":"Nat. Rev. Mater."},{"key":"53396_CR37","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1021\/acs.bioconjchem.3c00329","volume":"34","author":"D Maharshi","year":"2023","unstructured":"Maharshi, D., James, F. I., Anujan, R. & Kulkarni, A. Protein Corona Formation on Lipid Nanoparticles Negatively Affects the NLRP3 Inflammasome Activation. Bioconjug. Chem. 34, 1766\u20131779 (2023).","journal-title":"Bioconjug. Chem."},{"key":"53396_CR38","doi-asserted-by":"publisher","first-page":"5566","DOI":"10.1039\/D2BM00883A","volume":"10","author":"J Forster","year":"2022","unstructured":"Forster, J., Nandi, D. & Kulkarni, A. MRNA-Carrying Lipid Nanoparticles That Induce Lysosomal Rupture Activate NLRP3 Inflammasome and Reduce MRNA Transfection Efficiency. Biomater. Sci. 10, 5566\u20135582 (2022).","journal-title":"Biomater. Sci."},{"key":"53396_CR39","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.nano.2017.10.011","volume":"14","author":"T Li","year":"2018","unstructured":"Li, T. et al. Lysine-Containing Cationic Liposomes Activate the NLRP3 Inflammasome: Effect of a Spacer between the Head Group and the Hydrophobic Moieties of the Lipids. Nanomed. Nanotechnol., Biol. Med. 14, 279\u2013288 (2018).","journal-title":"Nanomed. Nanotechnol., Biol. Med."},{"key":"53396_CR40","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.nano.2013.12.003","volume":"10","author":"C Lonez","year":"2014","unstructured":"Lonez, C. et al. Cationic Lipid Nanocarriers Activate Toll-like Receptor 2 and NLRP3 Inflammasome Pathways. Nanomed. Nanotechnol., Biol. Med. 10, 775\u2013782 (2014).","journal-title":"Nanomed. Nanotechnol., Biol. Med."},{"key":"53396_CR41","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.smim.2017.08.015","volume":"34","author":"Y Granot","year":"2017","unstructured":"Granot, Y. & Peer, D. Delivering the Right Message: Challenges and Opportunities in Lipid Nanoparticles-Mediated Modified MRNA Therapeutics\u2014An Innate Immune System Standpoint. Semin. Immunol. 34, 68\u201377 (2017).","journal-title":"Semin. Immunol."},{"key":"53396_CR42","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1038\/s12276-023-01086-x","volume":"55","author":"Y Lee","year":"2023","unstructured":"Lee, Y., Jeong, M., Park, J., Jung, H. & Lee, H. Immunogenicity of Lipid Nanoparticles and Its Impact on the Efficacy of MRNA Vaccines and Therapeutics. Exp. Mol. Med. 55, 2085\u20132096 (2023).","journal-title":"Exp. Mol. Med."},{"key":"53396_CR43","first-page":"1","volume":"14","author":"X Zhu","year":"2023","unstructured":"Zhu, X. et al. Loss of NLRP3 Reduces Oxidative Stress and Polarizes Intratumor Macrophages to Attenuate Immune Attack on Endometrial Cancer. Front. Immunol. 14, 1\u201310 (2023).","journal-title":"Front. Immunol."},{"key":"53396_CR44","doi-asserted-by":"publisher","unstructured":"Ni, D. et al. Biomimetically Engineered Demi-Bacteria Potentiate Vaccination against Cancer. Adv. Sci. 4. https:\/\/doi.org\/10.1002\/advs.201700083 (2017).","DOI":"10.1002\/advs.201700083"},{"key":"53396_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0010051","volume":"5","author":"N Doshi","year":"2010","unstructured":"Doshi, N. & Mitragotri, S. Macrophages Recognize Size and Shape of Their Targets. PLoS One 5, 1\u20136 (2010).","journal-title":"PLoS One"},{"key":"53396_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcimb.2019.00117","volume":"9","author":"P Dhar","year":"2019","unstructured":"Dhar, P. & McAuley, J. The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation. Front. Cell. Infect. Microbiol. 9, 1\u20138 (2019).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"53396_CR47","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s00018-020-03656-y","volume":"78","author":"A Ciesielska","year":"2021","unstructured":"Ciesielska, A., Matyjek, M. & Kwiatkowska, K. TLR4 and CD14 Trafficking and Its Influence on LPS-Induced pro-Inflammatory Signaling. Cell. Mol. Life Sci. 78, 1233\u20131261 (2021).","journal-title":"Cell. Mol. Life Sci."},{"key":"53396_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-43087-w","volume":"13","author":"M Nejadmansouri","year":"2023","unstructured":"Nejadmansouri, M., Eskandari, M. H., Yousefi, G. H., Riazi, M. & Hosseini, S. M. H. Promising Application of Probiotic Microorganisms as Pickering Emulsions Stabilizers. Sci. Rep. 13, 1\u201318 (2023).","journal-title":"Sci. Rep."},{"key":"53396_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2020.00882","volume":"11","author":"L Tang","year":"2020","unstructured":"Tang, L. & Zhou, F. Inflammasomes in Common Immune-Related Skin Diseases. Front. Immunol. 11, 1\u201315 (2020).","journal-title":"Front. Immunol."},{"key":"53396_CR50","doi-asserted-by":"publisher","first-page":"24517","DOI":"10.1074\/jbc.M116.743815","volume":"291","author":"P Zhang","year":"2016","unstructured":"Zhang, P. et al. Vitamin B6 Prevents IL-1\u03b2 Protein Production by Inhibiting NLRP3 Inflammasome Activation. J. Biol. Chem. 291, 24517\u201324527 (2016).","journal-title":"J. Biol. Chem."},{"key":"53396_CR51","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.colsurfb.2017.04.018","volume":"155","author":"D Paolino","year":"2017","unstructured":"Paolino, D. et al. Interaction between PEG Lipid and DSPE\/DSPC Phospholipids: An Insight of PEGylation Degree and Kinetics of de-PEGylation. Colloids Surf. B Biointerfaces 155, 266\u2013275 (2017).","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"53396_CR52","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ejps.2016.11.029","volume":"99","author":"K Higashi","year":"2017","unstructured":"Higashi, K. et al. Composition-Dependent Structural Changes and Antitumor Activity of ASC-DP\/DSPE-PEG Nanoparticles. Eur. J. Pharm. Sci. 99, 24\u201331 (2017).","journal-title":"Eur. J. Pharm. Sci."},{"key":"53396_CR53","doi-asserted-by":"publisher","first-page":"117715","DOI":"10.1016\/j.molliq.2021.117715","volume":"344","author":"M Kowalska","year":"2021","unstructured":"Kowalska, M., Broniatowski, M., Mach, M., P\u0142achta, \u0141. & Wydro, P. Effect of Lipopolymer (DSPE-PEG750) on Phospholipid Monolayers and Bilayers Differing in the Structure of the Polar Head Group. J. Mol. Liq. 344, 117715 (2021).","journal-title":"J. Mol. Liq."},{"key":"53396_CR54","doi-asserted-by":"publisher","first-page":"116529","DOI":"10.1016\/j.molliq.2021.116529","volume":"335","author":"M Kowalska","year":"2021","unstructured":"Kowalska, M., Broniatowski, M., Mach, M., P\u0142achta, \u0141. & Wydro, P. The Effect of the Polyethylene Glycol Chain Length of a Lipopolymer (DSPE-PEGn) on the Properties of DPPC Monolayers and Bilayers. J. Mol. Liq. 335, 116529 (2021).","journal-title":"J. Mol. Liq."},{"key":"53396_CR55","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1039\/D2NR04987B","volume":"15","author":"Z Chen","year":"2022","unstructured":"Chen, Z. et al. Understanding the Rod-to-Tube Transformation of Self-Assembled Ascorbyl Dipalmitate Lipid Nanoparticles Stabilized with PEGylated Lipids. Nanoscale 15, 2602\u20132613 (2022).","journal-title":"Nanoscale"},{"key":"53396_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120599","volume":"602","author":"Z Chen","year":"2021","unstructured":"Chen, Z. et al. The Nanostructure of Rod-like Ascorbyl Dipalmitate Nanoparticles Stabilized by a Small Amount of DSPE-PEG. Int. J. Pharm. 602, 120599 (2021).","journal-title":"Int. J. Pharm."},{"key":"53396_CR57","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1002\/mabi.201200075","volume":"12","author":"SA Ferreira","year":"2012","unstructured":"Ferreira, S. A., Correia, A., Madureira, P., Vilanova, M. & Gama, F. M. Unraveling the Uptake Mechanisms of Mannan Nanogel in Bone-Marrow-Derived Macrophages. Macromol. Biosci. 12, 1172\u20131180 (2012).","journal-title":"Macromol. Biosci."},{"key":"53396_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110755","volume":"39","author":"SO Vasudevan","year":"2022","unstructured":"Vasudevan, S. O., Russo, A. J., Kumari, P., Vanaja, S. K. & Rathinam, V. A. A TLR4-Independent Critical Role for CD14 in Intracellular LPS Sensing. Cell Rep. 39, 110755 (2022).","journal-title":"Cell Rep."},{"key":"53396_CR59","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.immuni.2017.09.010","volume":"47","author":"I Zanoni","year":"2017","unstructured":"Zanoni, I., Tan, Y., Di Gioia, M., Springstead, J. R. & Kagan, J. C. By Capturing Inflammatory Lipids Released from Dying Cells, the Receptor CD14 Induces Inflammasome-Dependent Phagocyte Hyperactivation. Immunity 47, 697\u2013709.e3 (2017).","journal-title":"Immunity"},{"key":"53396_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2017.00335","volume":"8","author":"MP Madej","year":"2017","unstructured":"Madej, M. P., T\u00f6pfer, E., Boraschi, D. & Italiani, P. Different Regulation of Interleukin-1 Production and Activity in Monocytes and Macrophages: Innate Memory as an Endogenous Mechanism of IL-1 Inhibition. Front. Pharmacol. 8, 1\u201312 (2017).","journal-title":"Front. Pharmacol."},{"key":"53396_CR61","doi-asserted-by":"publisher","first-page":"45300","DOI":"10.1021\/acsami.1c14082","volume":"13","author":"D Nandi","year":"2021","unstructured":"Nandi, D. et al. Core Hydrophobicity of Supramolecular Nanoparticles Induces NLRP3 Inflammasome Activation. ACS Appl. Mater. Interfaces 13, 45300\u201345314 (2021).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"53396_CR62","doi-asserted-by":"publisher","unstructured":"Yang, Y., Wang, H., Kouadir, M., Song, H., Shi, F. Recent Advances in the Mechanisms of NLRP3 Inflammasome Activation and Its Inhibitors. Cell Death Dis. 10 https:\/\/doi.org\/10.1038\/s41419-019-1413-8 (2019).","DOI":"10.1038\/s41419-019-1413-8"},{"key":"53396_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmt.2021.101107","volume":"24","author":"P Makvandi","year":"2021","unstructured":"Makvandi, P. et al. Non-Spherical Nanostructures in Nanomedicine: From Noble Metal Nanorods to Transition Metal Dichalcogenide Nanosheets. Appl. Mater. Today 24, 101107 (2021).","journal-title":"Appl. Mater. Today"},{"key":"53396_CR64","volume":"133","author":"HC Lin","year":"2021","unstructured":"Lin, H. C. et al. Exploitation of a Rod-Shaped, Acid-Labile Curcumin-Loaded Polymeric Nanogel System in the Treatment of Systemic Inflammation. Mater. Sci. Eng. C. 133, 112597 (2021).","journal-title":"Mater. Sci. Eng. C."},{"key":"53396_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnagi.2022.879021","volume":"14","author":"HM Blevins","year":"2022","unstructured":"Blevins, H. M., Xu, Y., Biby, S. & Zhang, S. The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases. Front. Aging Neurosci. 14, 1\u201327 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"53396_CR66","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41420-023-01438-6","volume":"9","author":"T-G Yu","year":"2023","unstructured":"Yu, T.-G. et al. Oligomeric States of ASC Specks Regulate Inflammatory Responses by Inflammasome in the Extracellular Space. Cell Death Discov. 9, 142 (2023).","journal-title":"Cell Death Discov."},{"key":"53396_CR67","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1080\/21505594.2021.1926649","volume":"12","author":"Y Zhao","year":"2021","unstructured":"Zhao, Y. et al. A Virulent Bacillus Cereus Strain from Deep-Sea Cold Seep Induces Pyroptosis in a Manner That Involves NLRP3 Inflammasome, JNK Pathway, and Lysosomal Rupture. Virulence 12, 1362\u20131376 (2021).","journal-title":"Virulence"},{"key":"53396_CR68","doi-asserted-by":"publisher","unstructured":"Mathur, A. et al. Clostridium Perfringens Virulence Factors Are Nonredundant Activators of the NLRP 3 Inflammasome. EMBO Rep. 1\u201320. https:\/\/doi.org\/10.15252\/embr.202254600 (2023).","DOI":"10.15252\/embr.202254600"},{"key":"53396_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2020.09.004","volume":"228","author":"H Antushevich","year":"2020","unstructured":"Antushevich, H. Interplays between Inflammasomes and Viruses, Bacteria (Pathogenic and Probiotic), Yeasts and Parasites. Immunol. Lett. 228, 1\u201314 (2020).","journal-title":"Immunol. Lett."},{"key":"53396_CR70","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.abb.2019.02.015","volume":"670","author":"RI Campden","year":"2019","unstructured":"Campden, R. I. & Zhang, Y. The Role of Lysosomal Cysteine Cathepsins in NLRP3 Inflammasome Activation. Arch. Biochem. Biophys. 670, 32\u201342 (2019).","journal-title":"Arch. Biochem. Biophys."},{"key":"53396_CR71","doi-asserted-by":"publisher","unstructured":"Jing, W., Lo Pilato, J., Kay, C., Man, S. M. Activation Mechanisms of Inflammasomes by Bacterial Toxins. Cell. Microbiol. 23 https:\/\/doi.org\/10.1111\/cmi.13309 (2021).","DOI":"10.1111\/cmi.13309"},{"key":"53396_CR72","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/ncb0509-510","volume":"11","author":"J Mercer","year":"2009","unstructured":"Mercer, J. & Helenius, A. Virus Entry by Macropinocytosis. Nat. Cell Biol. 11, 510\u2013520 (2009).","journal-title":"Nat. Cell Biol."},{"key":"53396_CR73","first-page":"56","volume":"5","author":"X Feng","year":"2017","unstructured":"Feng, X. & Junsheng, Y. Lysosomal Calcium in Neurodegeneration. Messenger (Los Angel) 5, 56\u201366 (2017).","journal-title":"Messenger (Los Angel)"},{"key":"53396_CR74","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.4049\/jimmunol.170.6.3029","volume":"170","author":"D Brough","year":"2003","unstructured":"Brough, D. et al. Ca 2+ Stores and Ca 2+ Entry Di Erentially Contribute to the Release of IL-1B and IL-1\u03b1 from Murine Macrophages. J. Immunol. 170, 3029\u20133036 (2003).","journal-title":"J. Immunol."},{"key":"53396_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/cddis.2015.277","volume":"6","author":"JR Yaron","year":"2015","unstructured":"Yaron, J. R. et al. K+ Regulates Ca2+ to Drive Inflammasome Signaling: Dynamic Visualization of Ion Flux in Live Cells. Cell Death Dis. 6, 1\u201311 (2015).","journal-title":"Cell Death Dis."},{"key":"53396_CR76","doi-asserted-by":"publisher","first-page":"108719","DOI":"10.1016\/j.intimp.2022.108719","volume":"108","author":"Y Qiu","year":"2022","unstructured":"Qiu, Y. et al. Mitochondrial DNA in NLRP3 Inflammasome Activation. Int. Immunopharmacol. 108, 108719 (2022).","journal-title":"Int. Immunopharmacol."},{"key":"53396_CR77","doi-asserted-by":"publisher","first-page":"5230","DOI":"10.4049\/jimmunol.1301490","volume":"191","author":"ME Heid","year":"2013","unstructured":"Heid, M. E. et al. Mitochondrial Reactive Oxygen Species Induces NLRP3-Dependent Lysosomal Damage and Inflammasome Activation. J. Immunol. 191, 5230\u20135238 (2013).","journal-title":"J. Immunol."},{"key":"53396_CR78","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00394-021-02665-2","volume":"61","author":"T Kumrungsee","year":"2022","unstructured":"Kumrungsee, T., Zhang, P., Yanaka, N., Suda, T. & Kato, N. Emerging Cardioprotective Mechanisms of Vitamin B6: A Narrative Review. Eur. J. Nutr. 61, 605\u2013613 (2022).","journal-title":"Eur. J. Nutr."},{"key":"53396_CR79","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.2147\/JIR.S409699","volume":"16","author":"Y Teng","year":"2023","unstructured":"Teng, Y. et al. The Emerging Roles of Pyroptosis, Necroptosis, and Ferroptosis in Non-Malignant Dermatoses: A Review. J. Inflamm. Res. 16, 1967\u20131977 (2023).","journal-title":"J. Inflamm. Res."},{"key":"53396_CR80","first-page":"46","volume":"12","author":"D Mikhaylov","year":"2019","unstructured":"Mikhaylov, D., Hashim, P., Nektalova, T. & Goldenberg, G. Systemic Psoriasis Therapies and Comorbid Disease in Patients with Psoriasis: A Review of Potential Risks and Benefits. J. Clin. Aesthet. Dermatol 12, 46\u201354 (2019).","journal-title":"J. Clin. Aesthet. Dermatol"},{"key":"53396_CR81","doi-asserted-by":"publisher","unstructured":"Jiao, Y. et al. Discovery of a Novel and Potent Inhibitor with Differential Species-Specific Effects against NLRP3 and AIM2 Inflammasome-Dependent Pyroptosis. Eur. J. Med. Chem. 232. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114194 (2022).","DOI":"10.1016\/j.ejmech.2022.114194"},{"key":"53396_CR82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-79139-8","volume":"11","author":"T Liu","year":"2021","unstructured":"Liu, T. et al. Evaluation of the Anti-Biofilm Effect of Poloxamer-Based Thermoreversible Gel of Silver Nanoparticles as a Potential Medication for Root Canal Therapy. Sci. Rep. 11, 1\u201316 (2021).","journal-title":"Sci. Rep."},{"key":"53396_CR83","doi-asserted-by":"publisher","unstructured":"Cook, M. T., Haddow, P., Kirton, S. B., McAuley, W. J. Polymers Exhibiting Lower Critical Solution Temperatures as a Route to Thermoreversible Gelators for Healthcare. Adv. Funct. Mater. 31 https:\/\/doi.org\/10.1002\/adfm.202008123 (2021).","DOI":"10.1002\/adfm.202008123"},{"key":"53396_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2017.e00390","volume":"3","author":"A Fakhari","year":"2017","unstructured":"Fakhari, A., Corcoran, M. & Schwarz, A. Thermogelling Properties of Purified Poloxamer 407. Heliyon 3, e00390 (2017).","journal-title":"Heliyon"},{"key":"53396_CR85","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.actbio.2019.03.036","volume":"89","author":"B ter Horst","year":"2019","unstructured":"ter Horst, B. et al. A Gellan-Based Fluid Gel Carrier to Enhance Topical Spray Delivery. Acta Biomater. 89, 166\u2013179 (2019).","journal-title":"Acta Biomater."},{"key":"53396_CR86","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/jbm.a.32558","volume":"93","author":"Y Chang","year":"2010","unstructured":"Chang, Y. et al. A Systematic SPR Study of Human Plasma Protein Adsorption Behavior on the Controlled Surface Packing of Self-Assembled Poly(Ethylene Oxide) Triblock Copolymer Surfaces. J. Biomed. Mater. Res. - Part A 93, 400\u2013408 (2010).","journal-title":"J. Biomed. Mater. Res. - Part A"},{"key":"53396_CR87","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/srt.12709","volume":"25","author":"L Binder","year":"2019","unstructured":"Binder, L., Maz\u00e1l, J., Petz, R., Klang, V. & Valenta, C. The Role of Viscosity on Skin Penetration from Cellulose Ether-Based Hydrogels. Ski. Res. Technol. 25, 725\u2013734 (2019).","journal-title":"Ski. Res. Technol."},{"key":"53396_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/pnasnexus\/pgad291","volume":"2","author":"W Liao","year":"2023","unstructured":"Liao, W. & Aranson, I. S. Viscoelasticity Enhances Collective Motion of Bacteria. PNAS Nexus 2, 1\u201310 (2023).","journal-title":"PNAS Nexus"},{"key":"53396_CR89","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1177\/1535370217710637","volume":"242","author":"E Desmet","year":"2017","unstructured":"Desmet, E., Ramadhas, A., Lambert, J. & Van Gele, M. In Vitro Psoriasis Models with Focus on Reconstructed Skin Models as Promising Tools in Psoriasis Research. Exp. Biol. Med. 242, 1158\u20131169 (2017).","journal-title":"Exp. Biol. Med."},{"key":"53396_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms18122514","volume":"18","author":"K Boch\u00e9nska","year":"2017","unstructured":"Boch\u00e9nska, K., Smoli\u0144ska, E., Moskot, M., Jak\u00f3bkiewicz-Banecka, J. & Gabig-Cimi\u0144ska, M. Models in the Research Process of Psoriasis. Int. J. Mol. Sci. 18, 1\u201317 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"53396_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-78292-4","volume":"10","author":"JE Neil","year":"2020","unstructured":"Neil, J. E., Brown, M. B. & Williams, A. C. Human Skin Explant Model for the Investigation of Topical Therapeutics. Sci. Rep. 10, 1\u20138 (2020).","journal-title":"Sci. Rep."},{"key":"53396_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40824-023-00415-5","volume":"27","author":"M Ahn","year":"2023","unstructured":"Ahn, M. et al. 3D Biofabrication of Diseased Human Skin Models in Vitro. Biomater. Res. 27, 1\u201313 (2023).","journal-title":"Biomater. Res."},{"key":"53396_CR93","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jaci.2020.04.034","volume":"147","author":"MP Sch\u00f6n","year":"2021","unstructured":"Sch\u00f6n, M. P., Manzke, V. & Erpenbeck, L. Animal Models of Psoriasis\u2014Highlights and Drawbacks. J. Allergy Clin. Immunol. 147, 439\u2013455 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"key":"53396_CR94","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.jaci.2017.07.045","volume":"141","author":"N Garzorz-Stark","year":"2018","unstructured":"Garzorz-Stark, N. et al. Toll-like Receptor 7\/8 Agonists Stimulate Plasmacytoid Dendritic Cells to Initiate TH17-Deviated Acute Contact Dermatitis in Human Subjects. J. Allergy Clin. Immunol. 141, 1320\u20131333.e11 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"53396_CR95","doi-asserted-by":"publisher","unstructured":"Elias, M. et al. IL-36 in Chronic Inflammation and Fibrosis - Bridging the Gap? J. Clin. Invest. 131 https:\/\/doi.org\/10.1172\/JCI144336 (2021).","DOI":"10.1172\/JCI144336"},{"key":"53396_CR96","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.jid.2021.06.019","volume":"142","author":"RS Gangwar","year":"2022","unstructured":"Gangwar, R. S., Gudjonsson, J. E. & Ward, N. L. Mouse Models of Psoriasis: A Comprehensive Review. J. Invest. Dermatol. 142, 884\u2013897 (2022).","journal-title":"J. Invest. Dermatol."},{"key":"53396_CR97","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1093\/hmg\/7.10.1537","volume":"7","author":"J Bhalerao","year":"1998","unstructured":"Bhalerao, J. Bowcock, A. M. The Genetics of Psoriasis: A Complex Disorder of the Skin and Immune System. Hum. Mol. Genet. 7, 1537\u20131545 (1998).","journal-title":"Hum. Mol. Genet."},{"key":"53396_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0058196","volume":"8","author":"SK Bromley","year":"2013","unstructured":"Bromley, S. K., Larson, R. P., Ziegler, S. F. & Luster, A. D. IL-23 Induces Atopic Dermatitis-Like Inflammation Instead of Psoriasis-Like Inflammation in CCR2-Deficient Mice. PLoS One 8, 1\u201310 (2013).","journal-title":"PLoS One"},{"key":"53396_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-017-0415-3","volume":"9","author":"WR Swindell","year":"2017","unstructured":"Swindell, W. R. et al. Imiquimod Has Strain-Dependent Effects in Mice and Does Not Uniquely Model Human Psoriasis. Genome Med 9, 1\u201321 (2017).","journal-title":"Genome Med"},{"key":"53396_CR100","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1038\/jid.2013.57","volume":"133","author":"W Jiang","year":"2013","unstructured":"Jiang, W. et al. A Toll-like Receptor 7, 8, and 9 Antagonist Inhibits Th1 and Th17 Responses and Inflammasome Activation in a Model of IL-23-Induced Psoriasis. J. Invest. Dermatol. 133, 1777\u20131784 (2013).","journal-title":"J. Invest. Dermatol."},{"key":"53396_CR101","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.yadr.2008.09.004","volume":"24","author":"LS Miller","year":"2008","unstructured":"Miller, L. S. Toll-Like Receptors in Skin. Adv. Dermatol. 24, 71\u201387 (2008).","journal-title":"Adv. Dermatol."},{"key":"53396_CR102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2019.03096","volume":"10","author":"E von Stebut","year":"2020","unstructured":"von Stebut, E. et al. IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications. Front. Immunol. 10, 1\u201315 (2020).","journal-title":"Front. Immunol."},{"key":"53396_CR103","doi-asserted-by":"publisher","unstructured":"Brembilla, N. C., Senra, L., Boehncke, W. H. The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond. Front. Immunol. 9. https:\/\/doi.org\/10.3389\/fimmu.2018.01682 (2018).","DOI":"10.3389\/fimmu.2018.01682"},{"key":"53396_CR104","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2147\/ITT.S240891","volume":"10","author":"M Mosca","year":"2021","unstructured":"Mosca, M. et al. The Role of IL-17 Cytokines in Psoriasis. ImmunoTargets Ther. 10, 409\u2013418 (2021).","journal-title":"ImmunoTargets Ther."},{"key":"53396_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2022.11124","volume":"23","author":"D Branisteanu","year":"2022","unstructured":"Branisteanu, D. et al. Update on the Etiopathogenesis of Psoriasis (Review). Exp. Ther. Med. 23, 1\u201313 (2022).","journal-title":"Exp. Ther. Med."},{"key":"53396_CR106","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1084\/jem.20060244","volume":"203","author":"JR Chan","year":"2006","unstructured":"Chan, J. R. et al. IL-23 Stimulates Epidermal Hyperplasia via TNF and IL-20R2-Dependent Mechanisms with Implications for Psoriasis Pathogenesis. J. Exp. Med. 203, 2577\u20132587 (2006).","journal-title":"J. Exp. Med."},{"key":"53396_CR107","first-page":"46","volume":"59","author":"R De","year":"2007","unstructured":"De, R. & Mignogna, C. The Histopathology of Psoriasis. Reumatismo 59, 46\u201348 (2007).","journal-title":"Reumatismo"},{"key":"53396_CR108","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.jid.2020.07.021","volume":"141","author":"YH Lo","year":"2021","unstructured":"Lo, Y. H. et al. Galectin-8 Is Upregulated in Keratinocytes by IL-17A and Promotes Proliferation by Regulating Mitosis in Psoriasis. J. Invest. Dermatol. 141, 503\u2013511.e9 (2021).","journal-title":"J. Invest. Dermatol."},{"key":"53396_CR109","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00403-005-0602-8","volume":"297","author":"AC Yazici","year":"2005","unstructured":"Yazici, A. C. et al. The Changes in Expression of ICAM-3, Ki-67, PCNA, and CD31 in Psoriatic Lesions before and after Methotrexate Treatment. Arch. Dermatol. Res. 297, 249\u2013255 (2005).","journal-title":"Arch. Dermatol. Res."},{"key":"53396_CR110","doi-asserted-by":"publisher","unstructured":"Lee, H. J., Kim, M. Challenges and Future Trends in the Treatment of Psoriasis. Int. J. Mol. Sci. 24 https:\/\/doi.org\/10.3390\/ijms241713313 (2023).","DOI":"10.3390\/ijms241713313"},{"key":"53396_CR111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21197041","volume":"21","author":"YR Woo","year":"2020","unstructured":"Woo, Y. R., Park, C. J., Kang, H. & Kim, J. E. The Risk of Systemic Diseases in Those with Psoriasis and Psoriatic Arthritis: From Mechanisms to Clinic. Int. J. Mol. Sci. 21, 1\u201327 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"53396_CR112","first-page":"68","volume":"15","author":"A Thatiparthi","year":"2022","unstructured":"Thatiparthi, A., Martin, A., Liu, J. & Wu, J. Risk of Skin Cancer with Phototherapy in Moderate-to- Severe Psoriasis. J. Clin. Aesthet. Dermatol. 15, 68\u201375 (2022).","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"53396_CR113","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jaad.2020.07.087","volume":"84","author":"CA Elmets","year":"2021","unstructured":"Elmets, C. A. et al. Joint AAD\u2013NPF Guidelines of Care for the Management and Treatment of Psoriasis with Topical Therapy and Alternative Medicine Modalities for Psoriasis Severity Measures. J. Am. Acad. Dermatol. 84, 432\u2013470 (2021).","journal-title":"J. Am. Acad. Dermatol."},{"key":"53396_CR114","doi-asserted-by":"publisher","first-page":"416","DOI":"10.4103\/2229-5178.142483","volume":"5","author":"A Coondoo","year":"2014","unstructured":"Coondoo, A., Phiske, M., Verma, S. & Lahiri, K. Side-Effects of Topical Steroids: A Long Overdue Revisit. Indian Dermatol. Online J. 5, 416 (2014).","journal-title":"Indian Dermatol. Online J."},{"key":"53396_CR115","first-page":"337","volume":"103","author":"SK Stacey","year":"2021","unstructured":"Stacey, S. K. & McEleney, M. Topical Corticosteroids: Choice and Application. Am. Fam. Physician 103, 337\u2013343 (2021).","journal-title":"Am. Fam. Physician"},{"key":"53396_CR116","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1080\/09546634.2021.1882659","volume":"33","author":"J Hwang","year":"2022","unstructured":"Hwang, J. & Lio, P. A. Topical Corticosteroid Withdrawal (\u2018Steroid Addiction\u2019): An Update of a Systematic Review. J. Dermatol. Treat. 33, 1293\u20131298 (2022).","journal-title":"J. Dermatol. Treat."},{"key":"53396_CR117","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11154-017-9411-6","volume":"18","author":"L Barrea","year":"2017","unstructured":"Barrea, L. et al. Vitamin D and Its Role in Psoriasis: An Overview of the Dermatologist and Nutritionist. Rev. Endocr. Metab. Disord. 18, 195\u2013205 (2017).","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"53396_CR118","unstructured":"Nicholas Brownstone, M. Psoriasis Therapies in 2024 and Beyond. Dermatology Times. https:\/\/www.dermatologytimes.com\/view\/psoriasis-therapies-in-2024-and-beyond (accessed 2024-04-07)."},{"key":"53396_CR119","doi-asserted-by":"publisher","unstructured":"Guo, J. et al. Signaling Pathways and Targeted Therapies for Psoriasis. Signal Transduct. Target. Ther. 8 https:\/\/doi.org\/10.1038\/s41392-023-01655-6 (2023).","DOI":"10.1038\/s41392-023-01655-6"},{"key":"53396_CR120","doi-asserted-by":"publisher","unstructured":"Surve, D. H., Jirwankar, Y. B., Dighe, V. D., Jindal, A. B. Long-Acting Efavirenz and HIV-1 Fusion Inhibitor Peptide Co-Loaded Polymer-Lipid Hybrid Nanoparticles: Statistical Optimization, Cellular Uptake, and In Vivo Biodistribution. Mol. Pharm. 17 https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c00773 (2020).","DOI":"10.1021\/acs.molpharmaceut.0c00773"},{"key":"53396_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2021.106024","volume":"167","author":"DH Surve","year":"2021","unstructured":"Surve, D. H. & Jindal, A. B. Development of Cationic Isometamidium Chloride Loaded Long-Acting Lipid Nanoformulation: Optimization, Cellular Uptake, Pharmacokinetics, Biodistribution, and Immunohistochemical Evaluation. Eur. J. Pharm. Sci. 167, 106024 (2021).","journal-title":"Eur. J. Pharm. Sci."},{"key":"53396_CR122","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1021\/acsami.3c18645","volume":"16","author":"A Fish","year":"2024","unstructured":"Fish, A. & Kulkarni, A. Flow-Induced Shear Stress Primes NLRP3 Inflammasome Activation in Macrophages via Piezo1. ACS Appl. Mater. Interf. 16, 4505\u20134518 (2024).","journal-title":"ACS Appl. Mater. Interf."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-53396-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-53396-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-53396-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T17:04:50Z","timestamp":1729616690000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-53396-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,19]]},"references-count":122,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["53396"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-53396-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,19]]},"assertion":[{"value":"3 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.S. and A.K. has filed a patent application on this research. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9035"}}